PATIENTS WITH HER2-LOW ADVANCED BREAST CANCER TREATED WITH T-DXD

Clinical trials for PATIENTS WITH HER2-LOW ADVANCED BREAST CANCER TREATED WITH T-DXD explained in plain language.

Never miss a new study

Get alerted when new PATIENTS WITH HER2-LOW ADVANCED BREAST CANCER TREATED WITH T-DXD trials appear

Sign up with your email to follow new studies for PATIENTS WITH HER2-LOW ADVANCED BREAST CANCER TREATED WITH T-DXD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for easing chemo sickness in advanced breast cancer

Symptom relief ENROLLING_BY_INVITATION

This study is observing how well a drug called NEPA prevents nausea and vomiting in people with advanced breast cancer who are receiving a specific chemotherapy called T-DXd. It will follow 100 patients to see how effective and safe NEPA is at controlling these side effects over …

Matched conditions: PATIENTS WITH HER2-LOW ADVANCED BREAST CANCER TREATED WITH T-DXD

Sponsor: Yeon Hee Park • Aim: Symptom relief

Last updated Apr 02, 2026 09:27 UTC

PATIENTS WITH HER2-LOW ADVANCED BREAST CANCER TREATED WITH T-DXD

Get alerted when new PATIENTS WITH HER2-LOW ADVANCED BREAST CANCER TREATED WITH T-DXD trials appear

New hope for easing chemo sickness in advanced breast cancer